These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4046835)

  • 1. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
    De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
    Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide.
    De Marinis L; Mancini A; Maira G; Anile C; Menini E; Barbarino A
    J Clin Endocrinol Metab; 1984 Mar; 58(3):405-9. PubMed ID: 6693543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
    Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
    Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
    Valensi P; Combes ME; Perret G; Attali JR
    J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
    Barbarino A; de Marinis L; Menini E; Anile C; Maira G
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas.
    Casper RF; Rakoff JS; Quigley ME; Gilliland B; Alksne J; Yen SS
    Am J Obstet Gynecol; 1980 Feb; 136(4):518-23. PubMed ID: 6766667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
    Serri O
    Horm Res; 1987; 27(1):36-41. PubMed ID: 3623428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.
    Prescott RW; Johnston DG; Taylor PK; Haigh J; Weightman DR; Hall K; Cook DB
    J Endocrinol Invest; 1985 Feb; 8(1):49-54. PubMed ID: 3921596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
    Seki K; Uesato T; Kato K; Shima K
    Endocrinol Jpn; 1984 Dec; 31(6):733-9. PubMed ID: 6532792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin-secreting adenomas: surgical results and long-term follow-up.
    Maira G; Anile C; De Marinis L; Barbarino A
    Neurosurgery; 1989 May; 24(5):736-43. PubMed ID: 2716983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G; Chernova T; Goncharov N
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Uesato T; Kato K; Shima K
    Endocrinol Jpn; 1985 Jun; 32(3):369-73. PubMed ID: 4042992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
    Brismar K
    Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.